WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...

The Bureau of Investigative Journalism (TBIJ) revealed that commonly used chemotherapy drugs around the world had failed ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...

Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly ...

Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...

In a pilot programme involving 840 patients with various cancers, the test successfully categorised individuals as either ...

Tennis legend Chris Evert, a two-time ovarian cancer survivor, is advocating for awareness and genetic screening after her ...

The shares of this leading pharmaceutical company are in focus after the company secured the USFDA's approval for its key drug used to treat ovarian cancer. In this article, we will dive deep into its ...